COMMUNIQUÉS West-GlobeNewswire

-
Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
08/09/2025 -
NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025
08/09/2025 -
Rapport Announces Proposed Public Offering of Common Stock
08/09/2025 -
Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering
08/09/2025 -
Abivax Presents First Half 2025 Financial Results
08/09/2025 -
Nora Mental Health Opens New Location in Dallas, TX, Bringing Compassionate, Accessible Mental Health Care to the Community
08/09/2025 -
Claisen Launches Direct-to-Consumer Personalized Kits for Gastrointestinal Diseases (Heartburn, Bloating, and Gas)
08/09/2025 -
Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds
08/09/2025 -
Tren Cycle for Bodybuilding: CrazyBulk Introduce Test and Tren Stack for Muscle Growth, Dosage, Benefits & Results
08/09/2025 -
Persephone Biosciences Hits 10,000 Families on Waitlist for First-of-Its-Kind Infant Synbiotic
08/09/2025 -
Most Popular Legal Steroids for Muscle Building from CrazyBulk: Best Selling Steroid Alternatives for Muscle Growth and Cutting in 2025
08/09/2025 -
Shiny Smile Veneers Surpasses 100,000 Smiles Transformed in 2025 as Demand for Lifestyle Dental Health Solutions Grows
08/09/2025 -
Go North Hemp Forecasts 100% Year-Over-Year Revenue Growth in 2025, Strengthening Market Leadership in Next-Gen Hemp Ingredients
08/09/2025 -
RadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025
08/09/2025 -
OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders’ Annual General Meeting of September 30, 2025
08/09/2025 -
OSE Immunotherapeutics fait le point sur les procédures en cours avant l’Assemblée Générale Annuelle des actionnaires du 30 septembre 2025
08/09/2025 -
Press Release : Sequana Medical Announces New Share Capital Amount and New Number of Shares
08/09/2025 -
Idorsia highlights very low real-world abuse potential of DORA class for insomnia treatment at WSC 2025
08/09/2025 -
BIO CEO John Crowley to Receive Prestigious Dennis K. Stone Award at BioNTX iC³® Summit
08/09/2025
Pages